Prosecution Insights
Last updated: April 19, 2026

BEIJING HANMI PHARMACEUTICAL CO., LTD.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18260725 ANTIBODY SPECIFICALLY BINDING TO CD47 AND ANTIGEN-BINDING FRAGMENT THEREOF FONTAINHAS, AURORA M 1675 Non-Final OA Jul 07, 2023
18260691 ANTIBODY SPECIFICALLY BINDING WITH PD-L1 AND ANTIGEN-BINDING FRAGMENT OF ANTIBODY VAN DRUFF, SYDNEY 1643 Non-Final OA Jul 07, 2023

Managing BEIJING HANMI PHARMACEUTICAL CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month